Young Diane C. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Incentive Stock Option
2024-06-11−15,000→ 0 totalExercise: $2.71Exp: 2029-07-08→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-06-11$2.71/sh+15,000$40,650→ 17,115 total
Footnotes (1)
- [F1]As of July 8, 2023, the option is fully vested.